Oncology Startup Oncare Raises ₹27 Cr in Series A Funding to Expand Cancer Care Access Across India

Healthcare startup Oncare has raised ₹27 crore (approximately $3 million) in a Series A funding round led by Sky Impact Capital. The round also witnessed participation from Huddle Ventures, Lotus Herbal Group, SteerX, and Tremis Capital.

The fresh capital will be used to expand Oncare’s presence across new metro cities while strengthening its footprint in Tier-2 and Tier-3 markets, where access to quality oncology care remains limited. The company also plans to invest significantly in technology to enhance clinical operations, care coordination, and overall patient experience.

Founded in 2023 by Amar Sneh and Deepak Kumar, Oncare is reimagining cancer care delivery in India through a distributed oncology care model. Unlike traditional healthcare providers that rely on building large, capital-intensive hospitals, Oncare partners with accredited hospitals and integrates medical, surgical, and radiation oncology services under a single, unified platform.

This asset-light approach allows the startup to scale faster while maintaining high clinical standards and reducing the overall cost of care for patients. By bringing together oncologists, diagnostics, treatment planning, and post-treatment care, Oncare ensures continuity and coordination throughout the patient journey.

With cancer cases rising steadily across India, especially outside major urban centers, Oncare aims to bridge the gap between quality treatment and accessibility. Its model enables patients in smaller cities to receive standardized, protocol-driven cancer care without needing to travel long distances to metro hospitals.

Commenting on the funding, the founders shared that their vision is to make high-quality oncology care more accessible, affordable, and patient-centric. “Cancer treatment is complex and emotionally demanding. Our focus is on simplifying the journey for patients by coordinating care seamlessly across hospitals and specialists,” they said.

Sky Impact Capital highlighted Oncare’s strong mission-driven approach and scalable model, noting that distributed healthcare platforms have the potential to transform specialty care delivery in emerging markets like India.

As Oncare expands into new geographies and deepens its technology capabilities, it is positioning itself as a key player in India’s evolving oncology ecosystem, bringing structured, integrated cancer care closer to patients, wherever they are.